Sort
85,873 grants matching “alzheimers”
Comprehensive characterization of the Drosophila transcriptome
$3,529,155Susan E Celniker · University Of Calif-Lawrenc Berkeley Lab · U01 · FY2011 · HG
Central and Peripheral Roles of TREM2 in Alzheimer's Disease
$3,528,849Bruce T Lamb · Indiana University Indianapolis · RF1 · FY2015 · AG
Epidemiology of Alzheimerâs disease resilience and risk pedigrees
$3,528,416John Sai Keong Kauwe · Brigham Young University · RF1 · FY2016 · AG
Boston Early Adversity and Mortality Study (BEAMS): Linking administrative data to long-term longitudinal studies
$3,528,185Daniel K. Mroczek · Northwestern University At Chicago · RF1 · FY2019 · AG
Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of Disease
$3,526,723John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Investigating the molecular basis of risk and resilience to Alzheimer's disease
$3,525,676Priyanka Narayan · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
APP-mediated signaling, sleep perturbations, and Alzheimer's disease mouse models
$3,525,662Angele Parent · University Of South Florida · RF1 · FY2019 · AG
Brain atrophy, cognitive impairment and Alzheimer's in a low CVD-risk population
$3,525,316Hillard S Kaplan · Chapman University · RF1 · FY2017 · AG
Charting vascular contributions to white matter disease in familial Alzheimer's disease and CADASIL
$3,524,983Joseph Arboleda-Velasquez · Schepens Eye Research Institute · RF1 · FY2018 · NS
Rush Alzheimer's Disease Core Center
$3,522,718David A Bennett · Rush University Medical Center · P30 · FY2020 · AG
Escitalopram for Agitation in Alzheimer Disease
$3,521,438Constantine G Lyketsos · Johns Hopkins University · R01 · FY2021 · AG
FUNCTIONAL AND HEALTH CHANGES OF THE ELDERLY
$3,515,515Duke University · R01 · FY2000 · AG
Towards a comprehensive signaling pathway map of parahippocampal vulnerability in Alzheimers Disease
$3,514,658Bin Zhang · Icahn School Of Medicine At Mount Sinai · RF1 · FY2017 · AG
GENETIC MODIFIERS OF CEREBROSPINAL FLUID TREM2 IN ALZHEIMER'S DISEASE
$3,509,903Carlos Cruchaga · Washington University · RF1 · FY2018 · AG
Metabolic Network Analysis of Biochemical Trajectories in Alzheimer's Disease
$3,509,523Rima F Kaddurah-Daouk · Duke University · RF1 · FY2017 · AG
Endogenous human antibodies in aging and Alzheimer's disease and the immune response to amyloid
$3,508,837Charles G Glabe · University Of California-Irvine · RF1 · FY2018 · AG
Minimizing ICU Neurological Dysfunction with Dexmedetomidine-induced Sleep (MINDDS II)
$3,506,058Oluwaseun Johnson-Akeju · Massachusetts General Hospital · R01 · FY2024 · AG
Administrative Core
$3,503,902Michael W Weiner · Northern California Institute/Res/Edu · U19 · FY2023 · AG
Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Study of India (LASI)-Genomic study.
$3,503,515Jinkook Lee · University Of Southern California · U01 · FY2020 · AG
Rush Alzheimer's Disease Core Center
$3,503,322David A Bennett · Rush University Medical Center · P30 · FY2019 · AG
Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study - COVID supplement
$3,500,000Susan Abushakra · Alzheon, Inc. · R01 · FY2022 · AG
High resolution longitudinal immune monitoring for elucidating immune aging dynamics
$3,500,000Mark M Davis · Stanford University · P01 · FY2024 · AI
High resolution longitudinal immune monitoring for elucidating immune aging dynamics
$3,500,000Mark M Davis · Stanford University · P01 · FY2023 · AI
High resolution longitudinal immune monitoring for elucidating immune aging dynamics
$3,500,000Mark M Davis · Stanford University · P01 · FY2022 · AI
Adult Changes in Thought (ACT) Research Program Core B: Clinical Core
$3,499,351Linda Kathleen McEvoy · Kaiser Foundation Research Institute · U19 · FY2024 · AG